An observational study of the association among interatrial adiposity by computed tomography measure, insulin resistance, and left atrial electromechanical disturbances in heart failure

Medicine (United States)

Volumn 95, Issue 24, 2016, Pages

  Hung, Chung Lieh ^a,b,c,d,e   Yun, Chun Ho ^a   Lai, Yau Huei ^a,b,c,d   Sung, Kuo Tzu ^a,b,c,d   Bezerra, Hiram G ^f   Kuo, Jen Yuan ^a,b,c   Hou, Charles Jia Yin ^a,b,c   Chao, Tze Fan ^g   Bulwer, Bernard E ^h   Yeh, Hung I ^a,b,c,d   Shih, Shou Chuan ^a   Lin, Shing Jong ^e   Cury, Ricardo C ⁱ  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Department of Medical Research ^*  (Taiwan)

^c MACKAY MEDICAL COLLEGE   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ Baptist Cardiac Vascular Institute   (United States)

Author keywords

Cardiometabolic profiles; Electromechanical; Heart failure; Strain; Visceral adiposity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; ATRIOVENTRICULAR GROOVE FAT; BLOOD PRESSURE; BODY FAT; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART ATRIUM REMODELING; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; INSULIN RESISTANCE; INTERATRIAL FAT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; OUTPATIENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIGIDITY; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL ADIPOSITY; WAIST CIRCUMFERENCE; ADIPOSE TISSUE; COMPLICATION; DIAGNOSTIC IMAGING; HEART ATRIUM; HEART ATRIUM FUNCTION; HEART STROKE VOLUME; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; X-RAY COMPUTED TOMOGRAPHY;

ADIPOSE TISSUE; ADIPOSITY; ATRIAL FUNCTION, RIGHT; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART ATRIA; HEART FAILURE; HUMANS; INSULIN RESISTANCE; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84976433935     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003912     Document Type: Article

References (46)

1. Melenovsky V, Borlaug BA, Rosen B, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007;49:198-207.
2. Welles CC, Ku IA, Kwan DM, et al. Left atrial function predicts heart failure hospitalization in subjects with preserved ejection fraction and coronary heart disease: longitudinal data from the Heart and Soul Study. J Am Coll Cardiol 2012;59:673-80.
3. Kuppahally SS, Akoum N, Burgon NS, et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation. Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 2010;3:231-9.
4. Tan YT, Wenzelburger F, Lee E, et al. Reduced left atrial function on exercise in patients with heart failure and normal ejection fraction. Heart 2010;96:1017-23.
5. Kurt M, Wang J, Torre-Amione G, et al. Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging 2009;2:10-5.
6. Kokubu N, Yuda S, Tsuchihashi K, et al. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function. Hypertens Res 2007;30:13-21.
7. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
8. van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008;117:43-51.
9. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy: clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol 2008;51:93-102.
10. Horwich TB, Fonarow GC. Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure. J Am Coll Cardiol 2010;26:283-93. 55.
11. Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008;117:1255-60.
12. Edelmann F, Wachter R, Schmidt AG, et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 2013;309:781-91.
13. Kumar A, Thota V, Dee L, et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996;183:949-58.
14. Han JM, Levings MK. Immune regulation in obesity-associated adipose inflammation. J Immunol 2013;191:527-32.
15. Van Tassell BW, Toldo S, Mezzaroma E, et al. Targeting interleukin-1 in heart disease. Circulation 2013;128:1910-23.
16. Liao ZY, Peng MC, Yun CH, et al. Relation of carotid artery diameter with cardiac geometry and mechanics in heart failure with preserved ejection fraction. J Am Heart Assoc 2012;1:e003053.
17. Nichols JH, Samy B, Nasir K, et al. Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr 2008;2:288-95.
18. Shin SY, Yong HS, Lim HE, et al. Total and Inter-atrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011;22: 647-55.
19. Grundy SM, Brewer HB Jr, Cleeman JI, et al. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-8.
20. Fan JG, Saibara T, Chitturi S, et al. What are the risk factors and settings for non-alcoholic fatty liver disease in asia-pacific? J Gastroenterol Hepatol 2007;22:794-800.
21. Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112: 666-73.
22. Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol 1920;53:320-9.
23. Morris DA, Gailani M, Vaz Pérez A, et al. Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr 2011;24:651-2.
24. Bahrami H, Bluemke DA, Kronmal R, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008;6:1775-83. 51.
25. Suzuki T, Katz R, Jenny NS, et al. Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2008;1:242-8.
26. Rizzo MR, Sasso FC, Marfella R, et al. Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. J Diabetes Complications 2015;29:88-92.
27. Sardu C, Carreras G, Katsanos S, et al. Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. BMC Cardiovasc Disord 2014;14:176.
28. Marfella R, Sasso FC, Siniscalchi M, et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol 2013;62:525-30.
29. Marfella R, Barbieri M, Sardu C, et al. Effects of a-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy. J Cardiol 2016;67: 153-61.
30. Petretta M, Colao A, Sardu C, et al. NT-proBNP, IGF-I and survival in patients with chronic heart failure. Growth Horm IGF Res 2007;17: 288-96.
31. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735.
32. Verdecchia P, Reboldi G, Schillaci G, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100: 1802-7.
33. Fujita M, Asanuma H, Kim J, et al. Impaired glucose tolerance: a possible contributor to left ventricular hypertrophy and diastolic dysfunction. Int J Cardiol 2007;118:76-80.
34. Lam CS, Donal E, Kraigher-Krainer E, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2011;13:18-28.
35. Dhoble A, Patel MB. Cardiac steatosis and myocardial dysfunction. J Am Coll Cardiol 2009;53:636.
36. Rijzewijk LJ, van der Meer RW, Smit JW, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008;52:1793.
37. Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263-71.
38. McGavock JM, Victor RG, Unger RH. Szczepaniak LS; American College of Physicians and the American Physiological Society. Adiposity of the heart, revisited. Ann Intern Med 2006;144:517-24.
39. van Heerebeek L, Hamdani N, Falcão-Pires I, et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012;126:830-9.
40. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-0.
41. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9.
42. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005;2:536-43.
43. Babcock MJ, Soliman EZ, Ding J, et al. Pericardial fat and atrial conduction abnormalities in the Multiethnic Study of Atherosclerosis (MESA). Obesity 2011;19:179-84.
44. Shirani J, Roberts WC. Clinical electrocardiographic and morphologic features of massive fatty deposits ("lipomatous hypertrophy") in the atrial septum. J Am Coll Cardiol 1993;22:226-38.
45. Muranaka A, Yuda S, Tsuchihashi K, et al. Quantitative assessment of left ventricular and left atrial functions by strain rate imaging in diabetic patients with and without hypertension. Echocardiography 2009;26: 262-71.
46. Cornier MA, Després JP, Davis N, et al. American Heart Association Obesity Committee of the Council on Nutrition; Physical Activity and Metabolism; Council on Arteriosclerosis; Thrombosis and Vascular Biology;Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing, Council on Epidemiology and Prevention; Council on the Kidney in Cardiovascular Disease, and Stroke Council. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011;124:1996-2019.